AbstrAct bAckground: Previous research has suggested possible sexrelated differences in executive functioning among cocaine users; however, no studies specifically explain sexrelated differences in neurocognitive impairment (NCI) among cocaine users receiving clinical care. Knowledge about this associa tion can aid in the development of targeted prevention strategies to reduce adverse health outcomes. This study was designed to examine the sexrelated differences in NCI among highrisk cocaine users receiving substanceabuse treatment. Methods: The Neuropsychological Impairment Scale (NIS) was administered to 199 cocaine users (98 men; 101 women), receiving methadone main tainance treatment, to assess selfreported NCI by identifying the patients' awareness of neuropsychological symptoms. We used Ttest comparison to find differences in NCI between men and women and multiple regression analysis to explore the relative contribution of sex to NCI. results: Consistent with prior work, high NCI was evident within this sample, as indicated by high scores on most of the NIS subscales. Women reported greater impairment than men, as evidenced by significantly higher scores on several NIS subscales, after controlling for demographic and other confounding variables. Interestingly, cocaine craving significantly predicted NCI among men but not among women, as suggested by the significant associa tion between cocaine craving and all except one of the NIS subscales. conclusIons: These findings suggest that cocaine users enter into treatment with a range of NCI -with women having significantly more neurocog nitive deficits than men -that may contribute to differential treatment outcomes. This highlights the need to include additional services such as neuropsy chological screening and sexspecific treatment programs to optimally reduce adverse health outcomes in these highrisk, cognitively impaired patients.
Introduction
Cocaine is one of the most commonly abused psychoactive substances in the United States. The National Survey on Drug Use and Health (NSDUH) estimated that in 2012 there were over 1.8 million current cocaine users, of which 639,000 persons had used cocaine for the first time within the past 12 months; this averages to approximately 1,800 initi ates per day. 1 Studies on the neurocognitive effects of cocaine abuse have shown a significant association between neuro psychological impairment and affective dysfunction. [2] [3] [4] [5] Par alleling the effects on cognitive performance, evidence from magnetic resonance imaging (MRI) studies has shown that repeated exposure to cocaine produces significant structural and metabolic abnormalities in the brain, predominantly in the areas considered crucial for executive control. 2, 3, [6] [7] [8] [9] [10] [11] [12] Given its addictive potential and negative health conse quences, cocaine abuse has been regarded as a major public health issue. 13 Accumulating research suggests that there are important differences in the patterns of cocaine abuse and addiction between the sexes. For example, women are more likely to have an earlier cocaine use debut than men, 14, 15 and women are just as likely as men to advance from first cocaine use to dependence 16 but tend to experience a more rapid progres sion to the negative consequences associated with cocaine dependence (ie, "telescoping effect"). 17, 18 Additionally, some studies report that women seeking treatment tend to have more severe cocaine use problems than men, and have a higher occurrence of comorbid psychiatric conditions such as anxiety disorder, depression, and posttraumatic stress dis order. [19] [20] [21] This vulnerability of women might be influenced by sexrelated differences in cognitive impairment among cocaine users. Consistent with this assumption, a study by van der Plas et al found that decision making was signifi cantly more impaired in women addicted to cocaine as com pared to men. 22 
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These findings point to possible sexrelated interactions between cocaine use and cognitive deficits; however, they do not specifically explain sexrelated differences in neu rocognitive impairment (NCI) among chronic cocaine users. Moreover, cocaine use is highly prevalent among patients receiving substanceabuse treatment and therefore is a clini cal concern. 23 Nevertheless, the interplay of this relationship remains untested among cocaineusing patients receiving clinical care. Therefore, studying sexrelated differences in NCI among highrisk cocaine users receiving substance abuse treatment can aid in the development of targeted pre vention strategies.
Accordingly, the objectives of the current study were to examine the sexrelated differences in neurocognitive impair ment among a sample of cocaine users receiving substance abuse treatment (ie, methadone maintenance treatment; MMT) and to explore the relative contributions of cocaine use variables and sex on selfreported NCI. We formulated two main hypotheses: 1) cocaine users participating in metha done maintainance treatment program will have high levels of neurocognitive impairment, and 2) compared to males, female cocaine users participating in methadone maintainance treat ment program will have a higher degree of neurocognitive impairment.
Methods
design. This was a retrospective secondary analysis of a subset of data collected from the parent study, which was a randomized clinical trial of a behavioral HIVrisk reduction intervention designed to reduce HIV risk among highrisk, drugdependent individuals participating in drug treatment. 24 The study protocol was approved by the Investigational Review Board (IRB) at the University of Connecticut, the Human Investigation Committee at Yale University, and received board approval from the APT Foundation MMP, Inc. and the study complied with the principles of the Declaration of Helsinki. Variables for cocaine use had been created for the primary study, and selfreported NCI was assessed using the Neuropsy chological Impairment Scale (NIS) described below. 25 sample. The parent study included 304 HIVnegative individuals, without any psychiatric comorbidities, enrolled in a communitybased methadone maintenance treatment (MMT) program who reported sex or drugrelated HIV transmission risk behavior. 24 For the purpose of this study, we included subjects who reported using cocaine in the past week. Among the 199 individuals who met the inclusion cri teria for this study, 98 (49.2%) were male. Onehundred and fortysix subjects (73.4%) were white, 18 (9%) were African American, 30 (15.1%) were Hispanic, and 5 (2.5%) described themselves as "other" minority. The subjects' average age was 33.9 (±9.5), years and the majority of the participants (67.8%) were never married. Onehundred and fortynine subjects (74.9%) were high school graduates, and 156 (78.4%) were unemployed.
All subjects were enrolled in an innercity MMT pro gram and were maintained on a stable dose of methadone. The mean (±SD) daily methadone dose was 57.2 (±24.9) mg. The subjects had been using cocaine regularly for about 11.9 (±8.8) years. Fortythree (21.6%) subjects used cocaine by intravenous route of administration, 112 (56.3%) by smok ing, and 44 (22.1%) intranasally. During the week prior to entering the study, subjects used 4.2 (±12.4) g of cocaine over a period of 0.9 (±1.7) days per week. Cocaine crav ing, which was assessed by asking the subjects to rate their desire for cocaine in the scale of 1 to 5 (1 = "not at all" and 5 = "extreme") during the previous week, was found to be "extreme" in 7 (3.5%) subjects and "not at all" among 117 (58.8%) subjects.
Assessment instrument. Neurocognitive measures. The NIS was administered to patients individually upon meeting the criteria for the study. It is a brief, selfreport screening measure used to assess NCI by identifying patients' awareness of neu ropsychological symptoms 25 and is generally used as a screen ing instrument in clinical settings. Although clinical diagnosis of NCI requires the use of a more comprehensive assessment battery of instruments, recent studies have stressed the need for rapid screening tools. 26 Validity studies that have compared the NIS with tests known to assess various cognitive impairments have found the NIS to be both a valid and reliable predictor of NCIs in diverse group of patient population. 25, [27] [28] [29] [30] The NIS is composed of 95 items rated on 5point scales, ranging from 0 (not at all) to 4 (extremely). These responses are used to compute three summary scores and seven clini cal subscale scores. There are also validity checks, which pro vide a background for the interpretation of the other scores (Table 1) . 28 For each subscale, sums of the point scale scores were totaled and then transformed to Tscores, which were used in the current analysis as a continuous variable. Generally, high levels on any of these scores are an indication of NCI. NIS scores less than 30T were considered low, scores between 30T and 50T were considered average, scores between 50T and 60T were considered high, and any score above 60T was considered very high. Procedure. Both the NIS and drug use measurements were assessed using the Audio ComputerAssisted Self Interview (ACASI). 24, 31 For the purpose of this study, the NIS measurements -including seven impairment subscales, three validity scores, three summary scores (Table 1) , and cocaineuse measurements -were taken only from the baseline assessment. All subjects were reimbursed for the time and effort needed to participate in the study, and this study was approved by the institution's IRB. data analysis. Data analysis proceeded as follows: 1) Ttests (on continuous variables) and chisquare analy ses (on categorical variables) were performed to determine whether the sex of participants were wellmatched on rel evant sociodemographic and drug use variables.) A ttest revealed that there was a difference between men and women in terms of age and years of cocaine use. Therefore, the effects of these characteristics as well as other variables including methadone dose, years in the MMT program, use of opiate in the past six months, and duration of opi ate use were adjusted in all of our analyses. NIS summary scores, clinical subscale scores, and NIS testtaking atti tude scores were then compared by sex using ANCOVA. 3) Multiple regression analysis was conducted to explore the relative contributions of cocaineuse variables and sex on selfreported NCI. 4) Regression analysis was conducted between NIS subscale scores and cocaineuse variables by sex in order to further explore sexrelated differences between male and female cocaine users. Both subjective tests (visual examination of the standardized residual scat terplots) and objective tests (Shapiro-Wilk test) satisfied all assumptions of normality, linearity, and homoscedastic ity between the predicted dependent variable scores and errors of prediction. Furthermore, the Durbin-Watson test statistic revealed no correlation in adjacent residuals, and the variance inflation factor (VIF) and tolerance statistic suggested no problem with multicollinearity. PValues were set at ,0.05 for all our planned multiple measures. [32] [33] [34] Effect sizes are reported as bivariate standardized beta coefficients in order to distinguish between different results with a clinical meaning. 35 The effect sizes can be classified following Cohen's classification as small, medium, and large effect size -0.1, 0.3, and 0.5, respectivelyfor bivariate standardized regression coefficients. 36, 37 There were no missing values in the dataset. SPSS software, ver sion 20.0, was used for all statistical analyses. results comparison between male and female participants on sociodemographics and drug-use variables. Aside from age and years of cocaine use, there was no significant difference between male and female participants. Men tended to be older and to have used cocaine for a longer time as compared to women (Tables 2 and 3) .
comparison between male and female participants on the nIs summary scores, clinical scales, and test-taking attitude scales. NIS Tscores on each subscale were coded as "high" if they were within the range of the normative data provided in the NIS manual and used in prior study (ie, 50T-60T). 25, 31 The degree of impairment on all of the NIS subscales, except for symptom intensity measure (SIM) and defensiveness (DEF), was found to be "high" (ie, ranged from 50T to 60T) among all participants in our sample rela tive to the general population norm. Furthermore, women had significantly higher scores on one of the three NIS summary scores: global measure of impairment (GMI) On the validity subscales assess ing testtaking attitudes, female patients had higher affective disturbance scores (AFF) [F (165) = 6.5, P , 0.012] as com pared to males ( Fig. 1 ; Table 4 ). The mean value of the response inconsistency (INC) score (male: 53.4T and female: 54.9T), which evaluates the individual's ability to respond in a coherent and consistent manner, does not reflect any unusual inconsistency in the par ticipants' NIS responses. The mean DEF score (male: 39.5T and female: 38.3T) suggests that participants had a positive and open attitude in completing the assessment and did not appear to have any unusual difficulty making social judgments. A marginally elevated affective disturbance score (male: 56.6T and female: 60.7T) suggested some degree of anxiety, depres sion, or poor stress tolerance among participants at the time of testing, which is not unusual for this patient population. Further clinical examination is recommended to determine the nature and extent of affective disturbance.
25
Multiple regression analysis: prediction of ncI among participants. The following variables, together with the NIS summary and clinical subscales, were entered simultaneously into a standard multiple regression analysis that allowed each variable to be evaluated for its ability to add to the prediction of NCI among participants: sex (0/1: female/male), cocaine crav ing (0/1; not at all/yes), years of cocaine use, frequency (day) of cocaine use in the previous week, amount (in grams) of cocaine use in the previous week, plan to stop using cocaine (0/1; no/yes), and cocaine last used (day).
The full model accounted for between 32.4% and 38.6% of the variance in each of the NIS summary scales and between 17% and 37.8% of the variance in each of the clinical subscales. Out of the nine NIS subscales, four showed a sta tistically significant and unique relationship with sex, namely GMI, COG, ATT, and ACD, thus indicating a greater level of impairment for men vs women (Table 5) . exploration of associations between ncI and cocaineuse variables by sex. Regression analyses were conducted between NIS subscale scores and cocaineuse variables (ie, those found to be significant in regression model) by sex in order to further explore differences between men and women. Interestingly, cocaine craving contributed significantly to all NIS summary scores, and all clinical subscales except FRU for men. Similarly, the plan to use cocaine in the next three months was significantly associated with the cognitive impairment of repeatedly use cocaine. [2] [3] [4] [5] Consistent with other studies with this target population, relatively high levels of neurocogni tive impairment was evident in this group of participants, as indicated by average scores between 50T and 60T for most of the NIS subscales [ie, GMI, critical items (CRIT), COG, ATT, MEM, FRU, learningverbal (LV), ACD, INC, and AFF]. In addition, the current study assessed the potential sexrelated differences in selfreported NCI among cocaine users receiving clinical care. This is the first study, to our knowledge, to employ the NIS assessment to study sexrelated differences in selfreported neurocognitive impairment among cocaine users enrolled in methadonemaintained treatment program.
Our sample of women reported more impairment than men, as indicated by significantly higher scores on GMI, COG, ATT, FRU, ACD, and AFF (after controlling for age, years of cocaine use, methadone dose, years in MMT pro gram, use of opiate in the past six months, and duration of opiate use). The female participants' significantly higher score on GMI scale (P , 0.015) indicates a stronger likelihood of neuropsychological impairment as compared to their male counterparts. This difference in elevated GMI score may have been partly explained by a history of neurological illness or injury, as suggested by a higher CRIT score among women as compared to men, although it was not significantly differ ent (Table 4) 25 . Also, a significantly higher AFF score among women (P ,.012) suggests that general psychological distress may have contributed more to this differential cognitive dif ficulty compared to men.
In addition, women scored significantly higher than men on COG score (P , 0.019), which suggests a higher degree of cognitive impairment, such as slowness of mentation of praxis, fatigue, confusion, and mental efficiency, among women as compared to men. A significantly higher score on ATT scale among women (P , 0.002) signifies greater memory com plaints and symptoms of general cognitive impairment. The FRU, which was also found to be significantly higher among women (P , 0.034), suggests the presence of a higher degree Table 6 . associations between neurocognitive impairment and cocaine-use variables by sex. of symptoms, consistent with "organic personality disorder", such as irritability, anger, or temper. Furthermore, higher score on the ACD scale among women (P , 0.025), as compared to men, indicates higher degree of cognitive deficits associated with neurological impairment. These findings provide support to the notion that sex related differences in neurocognitive deficit exist among cocaine users, which may be both theoretically and clini cally meaningful. This was consistent with our central pre diction that NCI among cocaine users is sexspecific -with women having significantly higher degree of neurocognitive impairments than men. The results are also consistent with a previous finding, which reported significantly more execu tive impairment in women addicted to cocaine as compared to their male counterparts. 22 The higher degree of cognitive impairment among female cocaine users is accompanied by higher patterns of psychiatric, medical, social, family, and employment problems compared to that of male cocaine users. 22 The sexrelated differences in neurocognitive deficits among cocaine users may have been moderated to a degree by neurobiological development through hormonal influences, though this is well beyond the scope of this study. Estradiol, which is known to influence many drugrelated behaviors, has been linked to greater sensitization to cocaine use. 38, 39 Studies have shown that women have higher extrastriatal dopamine receptor binding in the frontal cortex, temporal cortex, and thalamus 40, 41 and higher striatal dopamine transporter levels in the caudate nucleus and putamen. 42 Likewise, neuroimag ing studies have confirmed an increase in D 2 receptor levels in the frontal cortex of female cocaine users. 40, 43, 44 Thus, the effects of higher doses of circulating estradiol in the neural circuits may lead to an increased vulnerability to cocaine use among women. 45 Overall, this evidence -along with findings from the current study -point to a differential sexrelated interaction on NCI among cocaine users. Furthermore, it pro vides a platform for further and more exhaustive research to investigate sexrelated association of neurocognitive deficits among male and female cocaine users.
One unexpected and intriguing finding was that cocaine craving significantly predicted NCI among men but not among women, as indicated by the significant association between cocaine craving and all NIS subscales, except for the FUS scale, among male cocaine users. This may suggest that impairment in this sample of men may be relatively temporary and moderated by cocaine craving. Similar relationships have been reported between selfreported impairment and cocaine craving among HIVseronegative, cocainedependent, metha donemaintained patients. 46 Previous studies have shown that craving for food and nicotine has a significant impact on cog nitive functioning, but the specific impact of cocaine craving, especially the differential impact between men and women, has not been investigated to date. 47, 48 Future studies will need to be conducted to examine the effects of repeated cocaine use and cocaine craving on neuropsychological impairment -as well as the directionality of these effects -among cocaine dependent patients at different stages of clinical care.
limitations and future research. Several limitations of our study must be acknowledged. First, the symptoms of NCI were assessed using the NIS, which is a selfreported screening instrument. This instrument does not provide a comprehensive assessment of NCI and does not measure all possible cognitive domains. It is, however, an easy toadminister assessment tool that provides a quick and accurate picture of neuropsychological symptoms, eliciting relevant diagnostic information, and has been used widely among this patient population. [28] [29] [30] [31] 46 Second, we relied on the selfreport assessment approach, which may have con strained our ability to precisely detect some variables due to the participants' reluctance to report socially undesir able behaviors, such as cocaine use and NCI components. This may have been moderated, however, by the use of the ACASI assessment approach, which provided partici pants with a high level of privacy. Third, this study does not address directionality of the association between cog nitive impairments and cocaine use -whether cognitive impairments represent predisposing traits or consequences of cocaine use. Such knowledge could further inform the development of tailored treatment approaches. Fourth, a number of studies have demonstrated that pharmacological treatments (ie. methadone maintenance treatment) for substanceabuse disorders can lead to neurocognitive defi cits. [49] [50] [51] [52] Thus, the level of cognitive deficit seen among our sample may have been interfered due to use of methadone. We did, however, account for the effect of methadone on differences in NCI within our sample by controlling for "methadone use" and "years in MMT program".
conclusion and recommendations
The present study contributes to the notion that cocaine dependent, methadonemaintained women and men may enter into substanceabuse treatment with a range of cog nitive impairments. Furthermore, a sexrelated difference of neurocognitive deficits -with cocaineaddicted women having significantly more impaired decisionmaking ability than cocaineaddicted men -may contribute to differential treatment outcomes among male and female cocaine users. Indeed, there is evidence that tailoring behavioral interven tions -based on demographics such as sex -can be more efficacious as opposed to using a onesizefitsall approach. Surprisingly, there have been very few randomized trials of addiction treatment programs that include additional services such as neuropsychological testing services and sexspecific treatment programs. 53 Future work in this area is essential, as it may have direct implications for the development of spe cifically tailored interventions designed to optimally reduce adverse health outcomes in these highrisk, cognitively impaired patients.
